TRIB (Trinity Biotech) Total Liabilities: $177.15 Mil (As of Dec. 2025)

What is Trinity Biotech Total Liabilities?

Trinity Biotech TRIB +17.06% 25 Total Liabilities is $177.15 Mil as of Dec. 2025. GuruFocus rates TRIB with a GF Score™ of 25/100 and a GF Value™ of $0.73 (Possible Value Trap). The stock has 7 warning signs investors should review.

Trinity Biotech's Total Liabilities for the quarter that ended in Dec. 2025 was $177.15 Mil.

Trinity Biotech's quarterly Total Liabilities increased from Dec. 2024 ($138.47 Mil) to Jun. 2025 ($149.17 Mil) and increased from Jun. 2025 ($149.17 Mil) to Dec. 2025 ($177.15 Mil).

Trinity Biotech's annual Total Liabilities increased from Dec. 2023 ($83.38 Mil) to Dec. 2024 ($138.47 Mil) and increased from Dec. 2024 ($138.47 Mil) to Dec. 2025 ($177.15 Mil).

Trinity Biotech Total Liabilities Related Terms

Trinity Biotech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Trinity Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trinity Biotech Total Liabilities Chart

Trinity Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

119.21

94.28

83.38

138.47

177.15

Trinity Biotech Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Total Liabilities	Get a 7-Day Free Trial															83.38	123.76	138.47	149.17	177.15

25GF Score

Trinity Biotech PLC TRIB

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Trinity Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Trinity Biotech's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	141.209	+	(27.17	+	4.101
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	4.667	+	0	+	0)
	=	177.15

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	105.165	-	-71.982
	=	177.15

Trinity Biotech's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	141.209	+	(27.17	+	4.101
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	4.667	+	0	+	0)
	=	177.15

Total Liabilities	=	Total Assets (Q: Dec. 2025 )	-	Total Equity (Q: Dec. 2025 )
	=	105.165	-	-71.982
	=	177.15

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of $177.15 Mil mean?

Trinity Biotech (TRIB) has a Total Liabilities of $177.15 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Trinity Biotech and its competitors.

Is Trinity Biotech's Total Liabilities too high?

Trinity Biotech's current Total Liabilities is $177.15 Mil. Overall, Trinity Biotech has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Trinity Biotech's Total Liabilities compare to AIDX and NVNO?

Trinity Biotech's Total Liabilities of $177.15 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Medical Devices & Instruments company?

A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Trinity Biotech and its competitors. Trinity Biotech's current Total Liabilities is $177.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Trinity Biotech stock overvalued right now?

Based on GuruFocus' analysis, Trinity Biotech (TRIB) is currently considered Possible Value Trap. The stock's GF Value™ is $0.73, compared to a current price of $0.42 — trading 42.8% below its estimated fair value. The current Total Liabilities is $177.15 Mil. Trinity Biotech's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Trinity Biotech (TRIB), the current Total Liabilities is $177.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trinity Biotech (TRIB) Overvalued in 2026?

Based on GuruFocus' analysis, Trinity Biotech stock appears to be undervalued. The current stock price of $0.42 is trading 42.8% below its estimated GF Value™ of $0.73. GuruFocus considers Trinity Biotech to be Possible Value Trap.

Key valuation signals for TRIB:

Total Liabilities: $177.15 Mil
GF Value™: $0.73 vs. price of $0.42 (42.8% below fair value)
GF Score™: 25/100 with 7 warning signs

No single metric tells the full story. See the TRIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trinity Biotech Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies AIDX NVNO STME NXL VVOS XAIR TNON CSDX BMRA INBS ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8

Website https://www.trinitybiotech.com

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.

25GF Score

Get the complete analysis for TRIB

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42

Price

$0.73

GF Value

View TRIB Analysis

See Total Liabilities data for all stocks →